Howard M Fillit, MD
- CLINICAL PROFESSOR | Geriatrics and Palliative Medicine
- CLINICAL PROFESSOR | Medicine
- CLINICAL PROFESSOR | Neuroscience
Specialty:
Geriatric Medicine
Howard Fillit, MD is a board certified geriatrician and a neuroscientist. He is the founding Executive Director of the Institute for the Study of Aging, an Estée Lauder family foundation, and the Alzheimer’s Drug Discovery Foundation, organizations with a common mission of accelerating drug discovery for Alzheimer’s disease through venture philanthropy. Dr. Fillit has had a distinguished academic medicine career at The Rockefeller University and The Mount Sinai School of Medicine where he is currently a clinical professor of geriatrics, medicine and neuroscience. He is the author or co-author of more than 300 scientific and clinical publications, and is the senior editor of the leading international Textbook of Geriatric Medicine and Gerontology. Dr. Fillit has received several awards and honors including the Rita Hayworth Award for Lifetime Achievement from the Alzheimer’s Association. Throughout his career, he has maintained a limited private practice in consultative geriatric medicine with a focus on Alzheimer’s disease and related dementias.
Certifications
American Board of Internal Medicine
Education
BA, Cornell University
MD, S.U.N.Y. Upstate Medical University
Residency, Internal Medicine, Beth Israel Medical Center
Fellowship, Immunology, Rockefeller University
Fellowship, Nephrology, Society of the New York Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Fillit during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Eli Lilly and Company; Otsuka Pharmaceutical Co., Ltd.; Pinteon; Samus Therapeutics
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- CarePredict
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.